NCT06123299View on ClinicalTrials.gov

A Randomised, Partly-blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Bacterial Vaginosis Compared With an Untreated Control Group

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

May 14, 2024

Study Completion Date

September 4, 2024

Conditions
Bacterial Vaginosis
Interventions
DEVICE

pHyph

vaginal tablet

Trial Locations (5)

Unknown

CTC, Ebbe Park, Linköping

CTC, Karolinska, Solna

Kvinnoforskningsenheten, KS Huddinge, Stockholm

CTC MTC, Uppsala

451 53

CTC GoCo, Mölndal

Sponsors

Lead Sponsor

Gedea Biotech AB
All Listed Sponsors
lead

Gedea Biotech AB

INDUSTRY